K

Kaken Pharmaceutical Co Ltd
TSE:4521

Watchlist Manager
Kaken Pharmaceutical Co Ltd
TSE:4521
Watchlist
Price: 4 222 JPY -0.82% Market Closed
Market Cap: 159.9B JPY
Have any thoughts about
Kaken Pharmaceutical Co Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

87.2B
+21%
Revenue
Growth Rates:
1 Year
+21%
3 Years
+15%
5 Years
-5%
7 Years
-12%
10 Years
-2%
23.6B
+163%
Operating Income
Growth Rates:
1 Year
+345%
3 Years
+38%
5 Years
-9%
7 Years
-21%
10 Years
+36%
18.2B
+151%
Net Income
Growth Rates:
1 Year
+415%
3 Years
+41%
5 Years
-1%
7 Years
-15%
10 Years
+69%

Earnings Waterfall
Kaken Pharmaceutical Co Ltd

Revenue
87.2B JPY
Cost of Revenue
-34.3B JPY
Gross Profit
52.9B JPY
Operating Expenses
-29.3B JPY
Operating Income
23.6B JPY
Other Expenses
-5.3B JPY
Net Income
18.2B JPY

Income Statement
Kaken Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
89 466
N/A
93 083
+4%
93 889
+1%
100 058
+7%
104 630
+5%
108 165
+3%
109 730
+1%
108 325
-1%
106 936
-1%
103 264
-3%
101 479
-2%
100 218
-1%
99 160
-1%
99 405
+0%
98 430
-1%
97 598
-1%
96 091
-2%
94 123
-2%
94 165
+0%
92 365
-2%
91 814
-1%
91 759
0%
89 232
-3%
84 967
-5%
80 851
-5%
76 136
-6%
74 979
-2%
75 362
+1%
75 778
+1%
75 605
0%
76 034
+1%
75 778
0%
75 265
-1%
73 899
-2%
72 984
-1%
72 937
0%
72 336
-1%
72 096
0%
72 044
0%
72 148
+0%
87 245
+21%
Gross Profit
Cost of Revenue
(44 285)
(44 970)
(44 760)
(45 976)
(46 642)
(46 885)
(47 580)
(46 931)
(46 444)
(45 269)
(44 539)
(43 867)
(43 157)
(43 112)
(42 405)
(42 052)
(41 483)
(40 696)
(40 366)
(39 706)
(39 668)
(39 443)
(38 753)
(36 928)
(35 373)
(34 181)
(34 073)
(34 568)
(34 762)
(34 482)
(34 458)
(34 438)
(34 302)
(33 779)
(33 428)
(33 365)
(33 446)
(33 243)
(33 505)
(33 613)
(34 324)
Gross Profit
45 181
N/A
48 113
+6%
49 129
+2%
54 082
+10%
57 988
+7%
61 280
+6%
62 150
+1%
61 394
-1%
60 492
-1%
57 995
-4%
56 940
-2%
56 351
-1%
56 003
-1%
56 293
+1%
56 025
0%
55 546
-1%
54 608
-2%
53 427
-2%
53 799
+1%
52 659
-2%
52 146
-1%
52 316
+0%
50 479
-4%
48 039
-5%
45 478
-5%
41 955
-8%
40 906
-3%
40 794
0%
41 016
+1%
41 123
+0%
41 576
+1%
41 340
-1%
40 963
-1%
40 120
-2%
39 556
-1%
39 572
+0%
38 890
-2%
38 853
0%
38 539
-1%
38 535
0%
52 921
+37%
Operating Income
Operating Expenses
(27 861)
(27 460)
(28 498)
(28 302)
(27 720)
(27 571)
(27 004)
(27 385)
(27 666)
(27 585)
(26 233)
(26 092)
(26 084)
(26 833)
(28 529)
(30 052)
(30 091)
(29 734)
(29 207)
(27 009)
(26 166)
(25 195)
(23 967)
(23 201)
(22 928)
(22 926)
(23 118)
(23 616)
(23 974)
(24 395)
(24 512)
(24 641)
(24 726)
(24 551)
(31 558)
(32 337)
(33 589)
(34 376)
(29 026)
(29 565)
(29 341)
Selling, General & Administrative
(20 922)
(20 856)
(20 589)
(20 906)
(20 520)
(20 377)
(20 302)
(20 496)
(20 607)
(20 595)
(20 020)
(20 218)
(20 129)
(20 102)
(20 174)
(20 156)
(19 876)
(19 617)
(18 724)
(18 721)
(18 282)
(17 939)
(17 320)
(16 821)
(16 578)
(16 390)
(16 155)
(16 588)
(16 497)
(16 485)
(15 833)
(16 055)
(15 984)
(15 855)
(15 476)
(15 976)
(16 388)
(16 393)
(16 165)
(16 623)
(16 563)
Research & Development
(6 941)
(6 605)
(7 615)
(7 403)
(7 206)
(7 201)
0
(6 374)
(6 545)
(6 476)
(6 450)
(6 387)
(6 467)
(7 243)
(8 152)
(9 895)
(10 216)
(10 118)
(10 261)
(8 291)
(7 887)
(7 258)
(6 418)
(6 382)
(6 351)
0
(6 736)
(5 433)
(5 882)
(7 909)
(8 420)
(8 585)
(8 742)
(8 695)
(15 789)
(16 359)
(17 197)
(17 981)
(12 543)
(12 941)
(12 778)
Depreciation & Amortization
0
0
(300)
0
0
0
(305)
0
0
0
(275)
0
0
0
(204)
0
0
0
(224)
0
0
0
(231)
0
0
0
(227)
0
0
0
(258)
0
0
0
(291)
0
0
0
(317)
0
0
Other Operating Expenses
0
1
6
7
6
7
(6 397)
(515)
(514)
(514)
512
513
512
512
1
(1)
1
1
2
3
3
2
2
2
0
(6 536)
0
(1 595)
(1 595)
(1)
(1)
(1)
0
(1)
(2)
(2)
(4)
(2)
(1)
(1)
0
Operating Income
17 320
N/A
20 653
+19%
20 631
0%
25 780
+25%
30 268
+17%
33 709
+11%
35 146
+4%
34 009
-3%
32 826
-3%
30 410
-7%
30 707
+1%
30 259
-1%
29 919
-1%
29 460
-2%
27 496
-7%
25 494
-7%
24 517
-4%
23 693
-3%
24 592
+4%
25 650
+4%
25 980
+1%
27 121
+4%
26 512
-2%
24 838
-6%
22 550
-9%
19 029
-16%
17 788
-7%
17 178
-3%
17 042
-1%
16 728
-2%
17 064
+2%
16 699
-2%
16 237
-3%
15 569
-4%
7 998
-49%
7 235
-10%
5 301
-27%
4 477
-16%
9 513
+112%
8 970
-6%
23 580
+163%
Pre-Tax Income
Interest Income Expense
167
180
182
192
186
191
167
150
138
460
461
523
543
267
265
272
266
280
291
315
302
324
322
344
360
352
479
476
474
472
349
368
375
410
395
389
390
403
395
487
456
Non-Reccuring Items
(22)
(564)
(595)
(599)
(618)
(87)
(68)
(64)
(71)
(83)
(124)
(145)
(112)
(110)
(165)
(165)
(174)
(145)
(55)
(22)
(304)
(661)
(356)
(355)
(78)
245
(58)
(55)
(84)
(74)
(3 860)
(4 173)
(4 133)
(4 130)
(1 912)
(1 626)
(1 651)
(1 663)
(167)
(768)
(687)
Gain/Loss on Disposition of Assets
7
(1 180)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
4
246
381
0
379
135
195
195
195
0
2
2
1
0
(1)
(1)
0
0
0
Total Other Income
(509)
(467)
(1 607)
(1 456)
(1 356)
(66)
47
38
49
43
48
48
50
84
90
87
87
69
94
82
76
95
110
119
121
466
69
92
100
111
137
344
197
218
335
261
207
180
55
27
24
Pre-Tax Income
16 963
N/A
18 622
+10%
18 611
0%
23 917
+29%
28 480
+19%
33 747
+18%
35 292
+5%
34 133
-3%
32 942
-3%
30 830
-6%
31 092
+1%
30 685
-1%
30 400
-1%
29 701
-2%
27 686
-7%
25 688
-7%
24 696
-4%
23 897
-3%
24 922
+4%
26 025
+4%
26 054
+0%
26 882
+3%
26 592
-1%
25 192
-5%
23 334
-7%
20 092
-14%
18 657
-7%
17 827
-4%
17 728
-1%
17 432
-2%
13 885
-20%
13 238
-5%
12 678
-4%
12 069
-5%
6 817
-44%
6 260
-8%
4 246
-32%
3 396
-20%
9 796
+188%
8 716
-11%
23 373
+168%
Net Income
Tax Provision
(6 187)
(6 713)
(6 488)
(8 124)
(9 513)
(11 094)
(14 148)
(13 492)
(12 834)
(11 838)
(9 075)
(9 002)
(8 961)
(8 808)
(8 643)
(8 073)
(7 682)
(7 466)
(7 147)
(7 458)
(7 571)
(7 799)
(7 222)
(6 828)
(6 285)
(5 343)
(5 252)
(4 880)
(4 828)
(4 715)
(4 336)
(4 144)
(3 887)
(3 617)
(1 377)
(1 217)
(702)
(430)
(1 770)
(1 447)
(5 129)
Income from Continuing Operations
10 776
11 909
12 123
15 793
18 967
22 653
21 144
20 641
20 108
18 992
22 017
21 683
21 439
20 893
19 043
17 615
17 014
16 431
17 775
18 567
18 483
19 083
19 370
18 364
17 049
14 749
13 405
12 947
12 900
12 717
9 549
9 094
8 791
8 452
5 440
5 043
3 544
2 966
8 026
7 269
18 244
Net Income (Common)
10 776
N/A
11 909
+11%
12 122
+2%
15 792
+30%
18 966
+20%
22 651
+19%
21 143
-7%
20 639
-2%
20 106
-3%
18 992
-6%
22 017
+16%
21 684
-2%
21 439
-1%
20 893
-3%
19 043
-9%
17 615
-7%
17 015
-3%
16 431
-3%
17 775
+8%
18 566
+4%
18 482
0%
19 082
+3%
19 370
+2%
18 364
-5%
17 049
-7%
14 750
-13%
13 405
-9%
12 947
-3%
12 900
0%
12 717
-1%
9 549
-25%
9 094
-5%
8 792
-3%
8 452
-4%
5 440
-36%
5 043
-7%
3 544
-30%
2 966
-16%
8 025
+171%
7 269
-9%
18 243
+151%
EPS (Diluted)
256.57
N/A
290.46
+13%
290.88
+0%
385.17
+32%
462.58
+20%
552.46
+19%
510.54
-8%
503.39
-1%
490.39
-3%
463.21
-6%
536.71
+16%
528.87
-1%
535.97
+1%
522.32
-3%
470.55
-10%
440.37
-6%
425.37
-3%
413.69
-3%
445.78
+8%
467.94
+5%
473.31
+1%
490.35
+4%
494.89
+1%
471.87
-5%
440.25
-7%
384.19
-13%
347.37
-10%
337.97
-3%
339.75
+1%
336.27
-1%
251.44
-25%
240.53
-4%
234.27
-3%
225.54
-4%
144.79
-36%
134.58
-7%
93.91
-30%
78.32
-17%
212.66
+172%
191.94
-10%
481.71
+151%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.